Enoximone

Jump to: navigation, search
Enoximone
Enoximone svg.png
Clinical data
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Bioavailability50% (oral)
Protein binding85%
MetabolismHepatic oxidation
Elimination half-life4 to 10 hours
ExcretionRenal (60 to 70%)
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H12N2O2S
Molar mass248.302 g/mol
3D model (JSmol)

WikiDoc Resources for Enoximone

Articles

Most recent articles on Enoximone

Most cited articles on Enoximone

Review articles on Enoximone

Articles on Enoximone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Enoximone

Images of Enoximone

Photos of Enoximone

Podcasts & MP3s on Enoximone

Videos on Enoximone

Evidence Based Medicine

Cochrane Collaboration on Enoximone

Bandolier on Enoximone

TRIP on Enoximone

Clinical Trials

Ongoing Trials on Enoximone at Clinical Trials.gov

Trial results on Enoximone

Clinical Trials on Enoximone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Enoximone

NICE Guidance on Enoximone

NHS PRODIGY Guidance

FDA on Enoximone

CDC on Enoximone

Books

Books on Enoximone

News

Enoximone in the news

Be alerted to news on Enoximone

News trends on Enoximone

Commentary

Blogs on Enoximone

Definitions

Definitions of Enoximone

Patient Resources / Community

Patient resources on Enoximone

Discussion groups on Enoximone

Patient Handouts on Enoximone

Directions to Hospitals Treating Enoximone

Risk calculators and risk factors for Enoximone

Healthcare Provider Resources

Symptoms of Enoximone

Causes & Risk Factors for Enoximone

Diagnostic studies for Enoximone

Treatment of Enoximone

Continuing Medical Education (CME)

CME Programs on Enoximone

International

Enoximone en Espanol

Enoximone en Francais

Business

Enoximone in the Marketplace

Patents on Enoximone

Experimental / Informatics

List of terms related to Enoximone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.[1]

References

  1. Boldt J, Suttner S (September 2007). "Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone". Expert Opin Pharmacother. 8 (13): 2135–47. doi:10.1517/14656566.8.13.2135. PMID 17714066.

Linked-in.jpg